republic-os/legislation/us/states/de/150/sb-101.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.	The opioid epidemic spreading through Delaware has reached critical levels, with 210 fentanyl-related deaths in 2017. This legislation will update the schedule for Fentanyl analogues, consistent with language used by the Drug Enforcement Administration (DEA). The Forensic Chemistry Unit at the Division of Forensic Science has confirmed the presence of these analogues in Delaware, but some of which are not currently scheduled under Title 16. This is directly related to continuous structural modifications of Fentanyl by illicit manufacturers. This legislation will close that gap and provide clarity to Title 16, consistent with federal law, by addressing ever-changing structural modifications being made in the illicit manufacture of Fentanyl. This legislative is aimed to curb the manufacture and distribution of illicit Fentanyl analogues and has no impact on the legal manufacture of Fentanyl for medical use.	us/states/de	Delaware General Assembly	150	SB 101	Delaware SB 101 (150)	bill		enacted	John L. Mitchell Nicole Poore William Bush	1	7	2	2019-05-15	2019-07-17	openstates	ocd-bill/e0915e6b-357e-4bc0-bbd7-da6f64588331	https://legis.delaware.gov/BillDetail?LegislationId=47490	6df17fbcd902283f4e7f863f414524f38d4236dccb29f62a409734af60ecf024	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-de

Delaware SB 101 (150) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.

The opioid epidemic spreading through Delaware has reached critical levels, with 210 fentanyl-related deaths in 2017. This legislation will update the schedule for Fentanyl analogues, consistent with language used by the Drug Enforcement Administration (DEA). The Forensic Chemistry Unit at the Division of Forensic Science has confirmed the presence of these analogues in Delaware, but some of which are not currently scheduled under Title 16. This is directly related to continuous structural modifications of Fentanyl by illicit manufacturers. This legislation will close that gap and provide clarity to Title 16, consistent with federal law, by addressing ever-changing structural modifications being made in the illicit manufacture of Fentanyl. This legislative is aimed to curb the manufacture and distribution of illicit Fentanyl analogues and has no impact on the legal manufacture of Fentanyl for medical use.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Bill Text (committee substitute) — source

Votes

• 2/3 — 20–0 (pass) · upper
• 2/3 — 41–0 (pass) · lower

Sponsors

• John L. Mitchell — primary (person)
• Nicole Poore — primary (person)
• William Bush — primary (person)
• Anthony Delcollo — cosponsor (person)
• Brian Pettyjohn — cosponsor (person)
• Bruce C. Ennis — cosponsor (person)
• Bryant L. Richardson — cosponsor (person)
• David L. Wilson — cosponsor (person)
• David P. Sokola — cosponsor (person)
• Earl G. Jaques Jr. — cosponsor (person)
• Edward S. Osienski — cosponsor (person)
• Ernesto B Lopez — cosponsor (person)
• Franklin D. Cooke — cosponsor (person)
• Gerald W. Hocker — cosponsor (person)
• Harris B. McDowell — cosponsor (person)
• Kevin S Hensley — cosponsor (person)
• Paul S. Baumbach — cosponsor (person)
• Raymond Seigfried — cosponsor (person)
• Ruth Briggs King — cosponsor (person)
• Stephanie L. Hansen — cosponsor (person)
• Timothy D. Dukes — cosponsor (person)
• Trey Paradee — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2019-05-15 Introduced and Assigned to Health & Social Services Committee in Senate introduction, referral-committee
• 2019-06-05 Reported Out of Committee (Health & Social Services) in Senate with 5 On Its Merits committee-passage
• 2019-06-11 Passed By Senate. Votes: 20 YES 1 ABSENT passage
• 2019-06-12 Assigned to Health & Human Development Committee in House introduction, referral-committee
• 2019-06-19 Reported Out of Committee (Health & Human Development) in House with 7 On Its Merits committee-passage
• 2019-06-30 Passed By House. Votes: 41 YES passage
• 2019-07-17 Signed by Governor executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/e0915e6b-357e-4bc0-bbd7-da6f64588331. Confidence: reported (aggregated from official Delaware legislature records).